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TranscriptomicsDeoxynivalenol (DON) is a mycotoxin produced by several Fusarium species and is often detected in grains.
Because of its high abundance, there has been a large interest in the effects of DON in animals and humans.
DON is known to be immunosuppressive at high concentrations and immunostimulatory at low
concentrations. The present study aimed to acquire insight into the modes of action of DON. For this,
C57Bl6 mice were orally exposed to 5, 10, or 25 mg/kg bw DON for 3, 6, or 24 h and thymuses were subjected
to genome-wide expression microarray analysis. Gene set enrichment analysis (GSEA) demonstrated that
DON downregulated genes involved in proliferation, mitochondria, protein synthesis, and ribosomal proteins.
Furthermore, GSEA showed a selective downregulation of genes highly expressed at the early precursor
thymocytes stage. This indicates that early precursor thymocytes, particularly at the double-positive CD4+
CD8+ stage, are more vulnerable to DON than very early or late precursor thymocytes. There was a large
overlap of genes upregulated by DON with genes previously reported to be either upregulated during T cell
activation or upregulated during negative selection of thymocytes that recognize “self-antigens”. This
indicates that DON induces cellular events that also occur after activation of the T cell receptor, for example,
release of calcium from the endoplasmatic reticulum. This T cell activation in the thymus then evokes negative
selection and depletion of thymocytes, which provides a plausible explanation for the high sensitivity of the
thymus for DON exposure. The expression patterns of four genes indicative for some of the processes that
were affected after DON treatment were conﬁrmed using real-time PCR. Immunocytological experiments
with primary mouse thymocytes demonstrated the translocation of NFAT from the cytoplasm into the nucleus
upon exposure top DON, thus providing further evidence for the involvement of T cell activation.te of Food Safety, Wageningen
. Fax: +31 317 417717.
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Approximately 25% of the world's food crops are affected by fungal
produced toxins (mycotoxins) (Rotteret al., 1996).Deoxynivalenol (DON,
vomitoxin) belongs to the trichothecene mycotoxins, which are capable
of generating toxic effects upon ingestion of mould-contaminated cereal
grains in humans and farm animals. DON is produced by strains of
Fusarium graminearum and Fusarium culmorum, which are common
pathogens of cereals (Richard, 2007). Although DON is not as toxic as
other trichothecenes such as T-2 toxin, it is considered as one of themost
common toxic contaminants of wheat, corn, and barley. DON remains
stable during storage and processing and does not degrade at high
temperature (Rotter et al., 1996). Orally dosed mice show a peak uptake
ofDONwithin30 minalongwithdistribution inplasmaandmany tissues.Inmice orally exposed to 25 mg/kg bwDON, the toxinwas detected after
30 min in several organs including spleen and thymus with a rapid
decrease to concentrations close to control levels occurring over 24 h
(Azconaolivera et al., 1995; Pestka et al., 2008). DON undergoes de-
epoxidation by gut-microﬂora and is conjugated to glucuronides in the
liver. Resultantmetabolites are excreted fromthebodyviaurine and feces
(Pestka, 2007; Amuzie et al., 2008).
DON has a major effect on actively dividing cells including bone
marrow, spleen, and thymus cells, and, as a consequence, it has a large
effect on the immune system (Pestka et al., 2004). DON induces thymus
atrophy at concentrations above 10 mg/kg fed to BALB/c mice daily for a
week. Spleen weight was decreased, but less then thymus weight
(Robbana-Barnat et al., 1988). Thisﬁndingwas one of theﬁrst indications
that the immune system is a primary target of DON. The effects of
exposure to DON can be either immunosuppressive or immunostimu-
latory, depending on the length of exposure and dosage concentration.
Low doses of DON promote the expression of various cytokines and
chemokines in vitro and in vivo, which involves transcriptional or post-
transcriptional mechanisms (Zhou et al., 1997; Kinser et al., 2004; Pestka
et al., 2004). Relevant immunostimulatory effects include an increase in
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macrophages and T cells. High doses of DON cause rapid apoptosis of
leukocytes that manifests itself as immunosuppression. Extremely high
doses can cause a shock-like death in mice. When administered
intraperitoneally, the LD50 value for mice ranges from 49 to 70 mg/kg
bw, andwhen administered orally, from46 to 78 mg/kg bw(Forsell et al.,
1987; Pestka, 2007).
Kinser et al. (2004) performed a gene expression study on spleens
of mice orally exposed to 25 mg/kg DON for 2 h. They found many
genes altered by acute DON exposure. Most of the upregulated genes
were immediate early genes involved in immunity and inﬂammation.
A drawback of this study was the low number of genes on the
microarrays. So far, little data are available on the effect of DON on
gene expression in the thymus. The thymus is an important organ
where T cell differentiation, selection, and maturation occur. During T
cell selection, lymphocytes expressing receptors that recognize
foreign proteins are positively selected and lymphocytes that react
to self-antigens are negatively selected and go into apoptosis (Starr
et al., 2003). Disturbance of the development of thymocytes has a
major effect on the defence system.
The aim of the present study was to obtain a better insight in the
mechanism of action of DON in the mouse thymus using whole
genome microarrays. Male C57Bl6 mice were gavaged with different
doses of DON and were sacriﬁced after 3, 6, and 24 h. DON treatment
caused a rapid induction of gene expression. The effect of DON on the
number of affected genes (≥1.5× up- or downregulated, p value
b0.01) was highest after 3 h for the lowest andmiddle dose andmuch
lower after 24 h, indicating a reversible effect. In contrast, the highest
concentration of 25 mg/kg DON had an irreversible effect on the
number of genes affected. The biological interpretation of the
microarray data led to the hypothesis that DON induces thymocyte
depletion via induction of the T cell activation response that is quickly
followed by negative selection of thymocytes.
Materials and methods
Animals. The DON in vivo study was performed with 7-week-old
male C57BL/6 mice that were obtained from Harlan (Horst, The
Netherlands). Animals were kept at a housing temperature of 22 °C
and at a relative humidity of 30–70%. Lighting cycle was 12-h light
and 12-h dark. The treatment protocol was approved by the ethi-
cal committee for animal experiments at Wageningen University,
Wageningen, The Netherlands.
Treatment. The experiment included 60 mice, which were random-
ly divided into 12 different groups. DON was dissolved in ethanol and
then diluted with endotoxin-free water. The amount of ethanol was
kept the same for all mice (2.5 μl/g bw). Themice obtained one dose of
DON by oral gavage (5, 10, or 25 mg/kg bw). The control groups per
time point received only the vehicle ethanol. DON or vehicle was
administered to one mouse each every 10 min to keep the treatment
times constant. After 3, 6, or 24 h, the mice were sacriﬁced by cervical
dislocation under isoﬂurane anesthesia. The thymus was isolated,
immediately frozen in liquid nitrogen, and kept frozen until further
gene expression analysis. The doses used in this study were chosen
based on literature. The lowest dose used (5 mg/kg DON) was chosen,
because it resembles the total daily consumption of DON in mice
digesting a diet of 25 ppm DON. This level has been shown to result in
an increase of circulating IgA and changes in the expression levels of
different genes encoding cytokines, such as Il6 and TNFα, in the spleen
(Azconaolivera et al., 1995; Amuzie et al., 2008). The highest dose of
25 mg/kg DON is one-third of the LD50 of DON inmice (Azconaolivera
et al., 1995).
RNA isolation. Thymuses were homogenized in 1 ml of TRIzol
reagent (Invitrogen, Breda, The Netherlands) per 50–100 mg tissue,using a homogenizer (Pro Multi-Gen 7, PRO Scientiﬁc, Oxford, CT).
Subsequently, RNA was isolated following supplier's instructions.
After puriﬁcation using the RNeasy Mini Kit (Qiagen, Venlo, The
Netherlands), integrity, purity, and concentration were assessed by
automated gel electrophoresis (Experion, Biorad, Veenendaal, The
Netherlands) and spectrophotometrically at wavelengths of 230,
260, and 280 nm.
Preparation of labeled cRNA and microarray hybridization. One mi-
crogram of each individual RNA sample was ampliﬁed using a low
RNA Input Fluorescent Linear Ampliﬁcation Kit (Agilent Technologies,
Amstelveen, The Netherlands). Subsequently, the common reference
sample, Universal Mouse Reference RNA (Stratagene, Amsterdam, The
Netherlands), was labeled with Cy3 and the thymus RNAs were
labeled with Cy5. The labeled cRNAs were puriﬁed (QIAquick spin
columns, QIAGEN, Venlo, The Netherlands) and 1 μg of each sample
was hybridized to 4×44 K whole genome mouse oligo microarrays
(G4122F, Agilent) according to manufacturer's instructions (two-
color microarray-based gene expression analysis, Agilent). After a
17-h incubation period, slides were washed using various dilutions
of SSPE (sodium chloride, sodium phosphate, EDTA) buffer according
to the protocol provided by Agilent. Arrays were scanned using an
Agilent microarray scanner (G2565B). The ﬂuorescent readings from
the scanner were converted to quantitative ﬁles using Feature
Extraction 9.1 software (Agilent Technologies). Quality check of the
arrays was done using software package LimmaGUI in R version 2.3.1.
Four samples were removed from the analysis due to technical failure.
Data were imported in GeneMaths XT 1.5 (Applied Maths, St.
MartensLatem, Belgium), and spots with signal intensities below two
times background were excluded from subsequent analysis. Corrected
data were normalized and adjusted for random and systematic error
(Pellis et al., 2003).
Overview of signiﬁcantly up- and downregulated genes. Signiﬁcance
analysis ofmicroarrays (SAM) analysiswas applied to detect signiﬁcantly
affected genes for each treatment using the two-class unpaired
comparison (Tusher et al., 2001). The False Discovery Rate was set to
b0.5%. No additional ﬁltering on a threshold for up- or downregulation
was applied. Evaluation of the outcome of the SAM results showed that
the minimal ratio for up- or downregulation was 1.5.
Hierarchical clustering. Hierarchical clustering was done with the
programs Cluster (uncentered correlation; average linkage clustering)
and Treeview (Eisen et al., 1998).
Metacore. Metacore (GeneGo, St. Joseph, MI) is an online software
program that provides, among other options, pathway analysis of
microarray data. Groups of co-clustering genes were analyzed for
overrepresentation of genes from signaling and metabolic pathways
based on hypergeometric distribution (Ekins et al., 2006). Pathways
with a p valueb10−5 were considered signiﬁcant.
GSEA. Gene set enrichment analysis (GSEA) was performed to
discover the differential expression of biologically relevant sets
of genes that share common biological function or regulation (Sub-
ramanian et al., 2005). GSEA has the advantage that no initial ﬁltering is
applied to the data set to select for signiﬁcantly differentially expressed
genes. GSEA ﬁrst ranks all probe sets based on fold changes (algorithm
signal to noise) in expression between a treatment and the control.
Subsequently, by using pre-deﬁned sets of associated genes based on
prior biological knowledge, GSEA calculateswhether sets as awhole are
enriched at the top or bottom of the fold change-based ranking list, or
randomly distributed (Subramanian et al., 2005). This enables detection
of signiﬁcantly affected gene sets, while the fold change of expression of
the individual genes can be relatively modest. GSEA was performed for
all treatment groups vs. controls at same time point. Gene sets with a p
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regulated. Up- and downregulation of signiﬁcant gene sets were
visualized with heap maps. The p values were converted into Z values
to enable clustering. Gene sets obtained positive or negative Z values
when up- or downregulated, respectively. Hierarchical clustering was
done as described above.
For GSEA, ﬁve collections of gene sets were used:
1. Cell cycle: data taken from supplemental data of Whitﬁeld et al.
(2002) and Bar-Joseph et al. (2008). In these studies, cells were ﬁrst
synchronized at the G0 cell stage and then stimulated to retain the
cell cycle. Microarray analysis was performed to detect genes
upregulated during certain cell cycle stages. Up- or downregulation
of these gene sets is indicative for a higher or lower proliferation rate.
2. Gene ontology: gene sets (mouse gene symbols) were downloaded
from theGeneOntology Consortium(http://www.geneontology.org/).
This collection contains gene sets related to general cellular processes.
3. Lymphocyte signature database: gene sets were taken over from
Shaffer et al. (2001). A proportion of these gene sets are based on
results from expression proﬁling studies on lymphocytes.
4. Tissue-speciﬁc blood cell types: data taken from Su et al. (2004),
Lyons et al. (2007), Du et al. (2006), and Hoffmann et al. (2003).
This collection contains gene sets that are speciﬁcally highly
expressed in certain blood cell types.
5. TOX TFS target genes: contains gene sets related to (1) toxic action
of compounds or (2) target genes of toxicity-related transcription
factors. These gene sets were deduced from microarray data.
Molecular concepts analysis. Molecular concepts analysis enables to
visualize networks in which the overlap between gene sets based on
co-occurrence of genes are shown (Rhodes et al., 2007). This overlap
was calculated based on the genes that were responsible for a gene set
to be signiﬁcantly affected. For this, either the top 20% of the genes
being upregulated or the top 20% of the genes being downregulated
was used. Gene set selection for molecular concepts mapping was
more stringent than used for making heat maps. Gene sets were
selected on a p value b0.01 in combination with an FDR value b0.25
according to GSEA statistics. In addition, gene sets containing≤8
genes were excluded from the analysis. After applying these criteria,
74 upregulated and 80 downregulated gene sets remained. The
signiﬁcance of overlap between the gene sets was calculated based on
the binomial distribution using Venn-Mapper (Smid et al., 2003).
Gene sets showing signiﬁcant overlap (Z value N2.72 that is equal to
pb0.0001) were connected in a network that was visualized using
Cytoscape (Shannon et al., 2003).
Genes from the gene sets with high overlap (high Z values) were
clustered close to each other. Gene sets within a same cluster are
expected to have a similarity in biological effects. These gene sets
were merged, and heat maps showing the effects of all treatments on
the genes of those merged gene sets were generated using GSEA.
Isolation of primary thymocytes. Seven-week-old male C57BL/6
mice were obtained from the breeding colony of Wageningen
University and sacriﬁced by CO2 without any preceding treatment.
The protocol was approved by the ethical committee for animal
experiments at Wageningen University. The thymus was excised
aseptically and collected in 3 ml RPMI 1640 medium, containing
HEPES (Invitrogen Life Science, Breda, The Netherlands) with 10%
heat-inactivated Fetal Bovine Serum (FBS) (Invitrogen Life Science),
100 U/ml Penicillin, and 100 μg/ml streptomycin (Invitrogen Life
Science) (standard medium). The thymus was gently pressed
through a 70-μm nylon cell strainer (Falcon, Franklin Lakes, NJ) to
prepare a single-cell suspension. After centrifuging (10 min,
1200 rpm, 4 °C), the cell suspension was resuspended in 5 ml of red
blood cell lysis buffer (NH4Cl 155 mM, KHCO3 10 mM, EDTA 1 mM;
pH 7.4) and incubated for 5 min on ice. Cells were washed withstandard medium (10 min, 1200 rpm, 4 °C) and counted with a
Coulter Counter (Beckman Coulter, Woerden, The Netherlands). The
concentration of the cell suspensionswas adjusted to 0.25×106 cells/
ml using standard medium.
Immunocytology. Freshly prepared DON solutions in absolute
ethanol were diluted in standard medium and added to the primary
thymocyte cultures (in 6-well plates) to a ﬁnal concentration of 0.5 μM
DON. The ﬁnal ethanol concentration was. Upon exposure for 1 h at
37 °C, primary thymocytes were immobilized on poly-L-lysine-coated
slides (Menzel-Glaser, Braunschweig, Germany) using mild cytospin
centrifugation (6 min at 600×g) followed by incubation in 4%
paraformaldehyde with 0.025% glutaraldehyde in PBS for 30 min.
After blocking cells with 1% BSA and 0.01% Triton-X 100 in PBS for
45 min, they were washed in 0.1% acetylated BSA (AUrion,
Wageningen,NL) in PBS and incubated overnight at 4 °C with 1/100
dilution of a primary antibody directed against NFATC1 (Santa Cruz
Biotechnology) in 0.1% acetylated BSA in PBS. After extensive washing
in 0.1% acetylated BSA in PBS, the cells were incubatedwith 1/300 goat
anti-mouse–IgG1–FITC secondary antibody for 120 min at 37 °C. Slides
were washed in PBS, mounted in Vectashield containing DAPI
(Vectashield, Amsterdam, The Netherlands), and imaged with an
LSM510 (Carl Zeiss, Jena, Germany) confocal microscope.
Images of DAPI and FITC were acquired with 405- and 488-nm
excitation in multitrackmode to prevent cross-signals. Images were
obtained with 420- to 480-nm BP ﬁlter for DAPI and 505- to 530-nm
BP ﬁlter for FITC with a 63× Plan Apochromat objective NA1.4 to
obtain high z-resolution (b1.0 μm optical slice).
Real time RT-PCR. Expression levels of 4 genes in all samples used for
microarray analysisweremeasured bymeans of real time RT-PCR. These
genes were selected on the basis of the outcome of the microarray data
analysis. PCR primers were designed using Beacon designer 7.00 (Pre-
mier Biosoft International, Palo Alto, CA). Primers for CD80 were sense
5′-CGACTCGCAACCACACCATTAAG-3′ and antisense 5′-CCCGAAGG-
TAAGGCTGTTGTTTG-3′, for CD86 sense 5′-TCACAAGAAGCCGAA-
TCAGCCTAG-3′, and antisense 5′-GCTCTCACTGCCTTCACTCTGC-3′ for
ATF3 sense 5′-ATAGAAGAGGTCCGTAAGGCAAGG-3′ and antisense 5′-
TTATTACAGCAAACACAGCAACACAAG-3′ and for Ccl4 sense 5′-
CCCACTTCCTGCTGTTTCTCTTAC-3′ and antisense 5′-GCTCAGTTCAA-
CTCCAAGTCACTC-3′. One microgram RNA was converted into cDNA
using the iScript cDNA Synthesis Kit (bio-Rad). One sample was taken
along without reverse transcriptase to examine the presence of DNA
(-RT reaction). RT-PCR reactions were performed in triplicate, using
the Bio-Rad MyiQ Single-Color Real-Time PCR Detection System
(Veenendaal, The Netherlands). The reaction mixture contained 2 μl
of cDNA and 23 μl of iQ SYBR green super mix consisting of reaction
buffer with dNTPs, iTaq DNA polymerase, SYBER green I and
ﬂuorescein (Bio-Rad-170-8882). The reaction mixtures were incu-
bated for 3 min at 95 °C, followed by 40 cycles of ampliﬁcation. The
PCR settings were as follows: denaturation 15 s at 95 °C, annealing
45 s at 60 °C, and extension 1 min at 65 °C, with single ﬂuorescence
acquisition at 65 °C after each cycle. Hprt1 (sense 5′- TGGGCTTACC-
TCACTGCTTTCC-3′ and antisense 5′- CCTGGTTCATCATCG-
CTAATCACG-3′) and Actb (sense 5′- AGC CAT GTA CGT AGC CAT
CCA-3′ and antisense 5′- TCT CCG GAG TCC ATC ACA ATG-3′) were
selected as reference genes since these were not differentially
regulated by DON as judged from the microarray results. Normali-
zation was performed using the reference gene, and the relative
expression of the target genes was calculated. Data were analyzed by
MyQ5 software (Bio-Rad).
Results
Mice were gavaged with three different doses (5, 10, or 25 mg/kg
bw) of DON for three time periods (3, 6, and 24 h) and the thymuswas
Table 1
Relative thymus weight (mg/g bw) of mice treated with DON. Mice were treated with 0, 5, 10 and 25 mg/kg DON for 3, 6 and 24 hours.
Time DON
(mg/kg bw)
Mouse weight
(g)
SD Absolute thymus weight
(mg)a
Relative thymus weight
(mg/g BW)a
3 h 0 23,7 2.4 74,4 8.6 3,14 0.16
5 22,8 1.1 74,2 15.1 3,25 0.73
10 23,84 1.8 74,6 11.8 3,13 0.55
25 23,18 0.7 73,5 16.7 3,17 0.66
6 h 0 23,16 1.3 76,4 8.7 3,3 0.21
5 22,94 1.9 78,6 30.0 3,43 1.10
10 21,46 3.0 78,4 20.4 3,66 0.78
25 24,68 2.7 79,8 18.6 3,24 0.42
24 h 0 23,74 2.6 83,0 10.7 3,5 0.46
5 22,72 0.8 71,6 16.2 3,15 0.77
10 22,68 1.3 76,1 21.4 3,36 0.82
25 20,78 1.5 48,8** 10.3 2,35* 0.46
a: *: Pb0.01; **: Pb0.001 (Student's T test).
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kg bw DON for 24 h resulted in a decrease of the ratio between
thymus weight and body weight (Table 1). As determined by SAM,
treatment with 5 mg/kg DON resulted in 634 genes to be signiﬁcantly
affected within 3 h already. At this dose, the number of affected genes
decreased to 65 after 6 h and to 0 genes after 24 h. This decrease of
number of affected genes was also observed for the treatment with
10 mg/kg bw DON, i.e., 713, 117, and 23 genes affected after 3, 6 and
24 h, respectively. This indicates that after exposure to 5 and 10 mg/
kg DON, the mice recovered over time. This pattern was not observed
for the highest dose of 25 mg/kg, which is one-third of the LD50. This
resulted in a constant number of affected genes, i.e., 924, 1124, and
1707 after treatment for 3, 6, or 24 h, respectively.Fig. 1. Hierarchical clustering of DON-affected genes. The heat map shows 2026 spots repre
control in at least 3 out of 32 arrays. Gene expression levels are indicated by colors, red: upr
the control. Basically, six clusters of genes can be distinguished based on gene expression l
clusters.Hierarchical clustering and pathway analysis
Fig. 1 shows a hierarchical clustering for genes that were at least
2.6-fold up- or downregulated (2log ratio ofN |1.4|) vs. the average of
the controls in≥3 of the 32 arrays (selection of 2026 spots
representing 1555 genes). Six clusters can be distinguished. Cluster
1 contains genes that were mainly upregulated by 10 and 25 mg/kg
DON after 24 h. A large group of genes (cluster 2) were highly
upregulated by each of the DON doses within 3 h already. These genes
were also upregulated after 6 and 24 h by the highest DON dose but
were much less or not upregulated anymore by the lower doses at
these time points. The genes within cluster 3 were upregulated after
24 h and variably expressed in the 3- and 6-h control samples. Clustersenting 1555 genes that were ≥2.6 times up- or downregulated vs. the average of the
egulation, black: no regulation, and green: downregulation compared to the average of
evels. The affected biological processes are indicated to the right of the corresponding
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proportion of these genes were downregulated at 3 and 6 h, whereas
other genes of this cluster were upregulated at 3 h. Cluster 5 contains
genes downregulated after 3 and 6 h of treatment but less down-
regulated after 24 h. The genes of cluster 6 were ﬁrst downregulated
after 3 h and upregulated after 6 h.
Metacore analysis of the genes from the individual clusters revealed a
clear difference in functionality between the genes of cluster 2, 4, and 6.Fig. 2. DON treatment affects gene sets indicative for proliferation. (A) Overview of the effec
downregulation and red upregulation compared to controls. Black indicates no effect. Genes
downregulated after 6- and 24-h exposure to DON. (B) Heat map of the genes from the mer
ratios of treatment vs. the average of the control at the same time point. For visualization,
control samples. Colors represent relative gene expression levels, blue indicates low expresGenes from cluster 2 were involved in immune pathways, including the
IL-17 and IL-1 signallingpathway (pvalue: 10−13 and10−12, respectively)
and the Toll-like receptor pathway (p value: 10−9). The genes that were
downregulated at the latest time point (cluster 4)were part of several cell
cycle pathways, such as those involved in metaphase checkpoint control
and APC-mediated cell cycle regulation (p value: 10−25 and 10−20,
respectively). Genes from cluster 6were involved in the cell cycle aswell.
The twomost signiﬁcant pathwayswere “start of DNA replication in earlyt of DON on gene sets speciﬁcally upregulated during a cell cycle stage. Green indicates
highly expressed during the G1–S phase of the cell cycle were upregulated after 3 h and
ged proliferation related gene sets of Supplementary Fig. 2. The heat map contains 2log
six columns containing zeros were added, representing the relative expression of the
sion, red indicates high expression.
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Metacore analysis of genes from clusters 1, 3, and 5 did not result in
signiﬁcantly regulated pathways.
Gene set enrichment analysis (GSEA) and molecular concepts
mapping
Gene set enrichment analysis was used for the identiﬁcation of
gene sets affected by DON in order to unravel mechanisms of DON
toxicity. This enables the comparison of our results with results
already published in literature or derived from microarray studies.
A three-step approach was followed. Firstly, GSEA was performed
on each of the nine treatment groups in relation to the control
samples at the same time point. Up- and downregulation of signiﬁcant
gene sets were visualized in heat maps enabling comparison between
the treatment groups. This resulted in 264 gene sets, obtained from
ﬁve gene set collections, that were signiﬁcantly affected by at least
one treatment. Secondly, molecular conceptsmappingwas performed
to further facilitate the biological interpretation. This provided a
visualization of the overlap in genes among the signiﬁcant gene sets
from the combined gene set collections. Based on clusters of highly
similar gene sets, themain biological events were elucidated. Molecular
concepts mapping was performed for one treatment: 6-h exposure to
10 mg/kg. This treatment was selected since nearly all gene sets
affected by any treatment were also affected by this dose at this time
point. Thirdly, gene sets showing high overlap according to molecular
concepts mapping were merged. The rationale for this step was that a
high overlap is indicative for comparable biological effects. Heat maps
were made to investigate the expression of the individual genes of
merged gene sets for all treatment groups.
The results of the molecular concepts mapping for all gene sets are
shown in Supplementary Fig. 1. The gene sets upregulated by 6-
h exposure to 10 mg/kg DON clustered into ﬁve themes: lymphocyte
activation, inﬂammatory response, blood cell inﬁltration, late precursor
T cells, and a combination of cell adhesion and cytoskeleton (Supple-
mentary Fig. 1A). The gene sets downregulated by the same treatment
yielded ﬁve clusters as well: mitochondrion, ribosome, cytoplasm/
nucleus, early-precursor T cells, and proliferation (Supplementary
Fig. 1B).
Proliferation
A molecular concepts visualization of the gene sets that are
indicative for the proliferation rate is shown in Supplementary Fig. 2.
The downregulation of the cell cycle related gene sets indicates a
major inhibiting effect of DON on the proliferation. These gene sets
include genes that are speciﬁcally upregulated during a particular cell
cycle phase (Whitﬁeld et al., 2002; Bar-Joseph et al., 2008).
Interestingly, genes upregulated during the G1–S phase of the cell
cycle were upregulated after 3-h treatment with 5 μg/kg and
particularly 10 μg/kg DON (Fig. 2A). This indicates that 10 mg/kg
DON rapidly stimulates entry of cells into the G1–S phase of the cell
cycle but inhibits cell division shortly thereafter. A heat map of the
expression of the genes of the merged proliferation-related gene sets
is given in Fig. 2B. This ﬁgure (upper part of heat map at the left)
shows that many of the cell cycle genes were temporarily upregulated
during the ﬁrst 3 h.Fig. 3. DON upregulates gene sets related to lymphocyte activation. (A) Molecular concepts
gene sets were upregulated after 6-h exposure to 10 mg/kg DON. The size of the nodes co
connecting lines indicate the degree of overlap between the gene sets. The color of the nod
lymphocyte signature database; yellow: TOX TFS target genes. (B) Heat map of genes invol
average of the control at the same time point. For visualization, six columns containing z
represent relative gene expression levels, blue indicates low expression, red indicates high ex
Fig. 3. T cell activation genes were upregulated within 3 h and remained upregulated after
upregulated anymore after 24-h treatment with 5 and 10 mg/kg bw DON.T cell activation
As shown in Fig. 3A, genes that are upregulated in T lymphocytes
during the T cell activation response are also upregulated by DON.
These gene sets include NFkB, CD40, Fos, and Jun (Supplementary
Fig. 3), which are well-known for being induced by T cell activation
(Gwack et al., 2007). In agreement with this, NFkB target genes and
CD40 upregulated genes are also induced by DON (Fig. 3A). These T
cell activation-related genes were upregulated within 3 h. These
genes remain highly upregulated after 24 h for the highest dose of
DON but return within 24 h close to control levels for the lowest and
middle dose of DON (Fig. 3B).
Inﬂammatory response, blood cell inﬁltration, cell adhesion–cytoskeleton
DONupregulatedofmany inﬂammatory response-relatedgene sets
including chemokine activity, chemotaxis, inﬂammatory response, and
acute phase response (Supplementary Fig. 4A). These gene sets
contained many cytokine-related genes (Supplementary Fig. 4B). The
upregulation of gene sets such as dendritic cells, monocytes, and
polymorphonuclear leucocytes (Supplementary Fig. 5A and C) indi-
cates an inﬁltration of blood cells with phagocytotic ability. One other
cluster of gene sets upregulated by DON was related to cell adhesion
and cytoskeleton (Supplementary Fig. 6A). The expression pattern
over time of inﬂammatory response, blood cell inﬁltration, and cell
adhesion–cytoskeleton genes was remarkable similar to that of the T
cell activation-induced genes (Supplementary Figs. 4B, 5B, D and 6B).
Precursor T lymphocytes
Genes highly expressed in either the very earliest precursor T
lymphocytes stage (DN2) or the late precursor stages (CD4+ or CD8+)
were upregulated by DON treatment, while genes highly expressed in
early precursor cells of the double-positive stage (CD4+ and CD8+)
were downregulated by DON (Supplementary Fig. 7A, B, and D).
Genes highly expressed in early precursor stages DN3 and DN4 are
upregulated at 3 h and downregulated at 6 and 24 h (Supplementary
Fig. 7A and B). The downregulation of the early precursor marker
genes and the upregulation of the late precursor marker genes were
most apparent at 6 h for all doses and at 24 h for the highest dose of
DON (Fig. 4A and B, Supplementary Fig. 7C and E). After 24 h, gene
expression in thymuses of mice exposed to 5 and 10 mg/kg DON was
for the most part recovered. In marked contrast, the effects of 24-
h exposure to 25 mg/kg DONwere more severe than those after 3 and
6 h (Fig. 4, Supplementary Fig. 7C and E). These ﬁndings indicate that
the early precursor T lymphocytes that are at or close to the double-
positive stage are most sensitive for DON treatment.
Mitochondrion, ribosome, cytoplasm/nucleus
Genes encoding proteins for cellular components as mitochondria,
ribosomes, and cytoplasm/nuclei were downregulated by DON. The
molecular concepts picture for ribosomes also contains gene sets
related to mRNA splicing, nucleosome, protein synthesis, and
ribosomal RNA binding, indicating that genes involved in the entire
route for mRNA modiﬁcation to protein translation were down-
regulated (Fig. 5A). As shown in the heat map of Fig. 5B, thisvisualization of gene sets containing genes upregulated during T cell activation. These
rresponds to the number of genes of the gene set, and the width and boldness of the
es corresponds to the gene set collection from which the gene sets were taken. Green:
ved in T lymphocyte activation. The heat map contains 2log ratios of treatment vs. the
eros were added, representing the relative expression of the control samples. Colors
pression. The picture for all genes including gene symbols is provided in Supplementary
24-h treatment with 25 mg/kg bw DON. Most T cell activation-related genes were not
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Fig. 5. DON downregulates ribosome- and protein translation-related genes. (A) Molecular concepts visualization of gene sets involved in the route for mRNA modiﬁcation to protein
translation. Genes from these gene sets were downregulated. This visualization method is explained in the legend of Fig. 3A. Green nodes: lymphocyte signature database; purple nodes:
gene ontology. (B) Heat map of the genes from the merged gene sets of A. Downregulation of genes involved in ribosomal function was most severe after 6 h of exposure. The colors of
the heat maps are explained in the legend of Fig. 3B.
307S.W.M. van Kol et al. / Toxicology and Applied Pharmacology 250 (2011) 299–311downregulation was most apparent after 6 h. The expression patterns
of the gene sets related to mitochondria and cytoplasm/nucleus were
rather similar to that of the ribosome-related gene sets (Supplemen-
tary Figs. 8 and 9, respectively). Again many genes were upregulated
after 3 h and downregulated from 6 h onwards.Fig. 4. DON affects the relative abundance of precursor T lymphocytes. (A) Bottom part of a h
the double-positive stage. For this, genes of the gene sets shown in Supplementary Fig. 7B w
and remained downregulated after 24 h for the highest dose. Full heat map is shown in Su
lymphocytes, showing upregulation of these genes at 3 and 6 h of treatment. After 24 h, this u
kg DON. Full heat map is shown in Supplementary Fig. 7E. The colors of the heat maps areGenes upregulated during negative selection of thymocytes
The ﬁnding that DON induces a T cell activation response is of high
relevance, since T cell activation in the thymus induces apoptosis and
rapid depletion of the activated thymocyte (Starr et al., 2003). Thiseat map of genes highly expressed in early precursor lymphocytes, for the largest part of
ere merged. These genes were downregulated after treatment for 3 and 6 h for all doses
pplementary Fig. 7C. (B). Top part of a heat map of marker genes for late precursor T
pregulation was less apparent for 5 and 10 mg/kg DON but was more severe for 25 mg/
explained in the legend of Fig. 3B.
Fig. 6. Genes upregulated during negative selection of thymocytes are also upregulated by DON. Genes upregulated in double-positive thymocytes during negative selection were
taken from data published by Schmitz et al. (2003) The heat map shows the effect of DON on these genes. The majority of these genes were upregulated within 3 h of DON treatment.
The colors of the heat maps are explained in the legend of Fig. 3B.
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antigens”. This selection process occurs predominantly at the double-
positive stage (Starr et al., 2003). Our expression data suggest that the
double-positive precursor T lymphocytes are also themain target cells
of DON. These observations brought us to examinewhether genes that
were normally upregulated during negative selection of double-
positive thymocytes are also upregulated by DON in our experiment.
For this, we used a previously published gene set of 58 genes that are
upregulated within 2 h in mouse double-positive thymocytes after
induction of negative selection in vivo (Schmitz et al., 2003). From
these 58 genes, 51 could be linked to ourmicroarray data. As shown in
Fig. 6, themajority of these genes were upregulated within 3 h of DON
treatment as well. This indicates that DON induces molecular events
similarly to those induced by negative selection on thymocytes with
self-recognition.
Immunocytology
Many of the genes that are upregulated during negative selection
in the thymus (Schmitz et al., 2003) are also upregulated in our
experiment by DON. Negative selection in the thymus is initiated by a
T cell activation response to self-antigens. This ﬁnding, therefore,
further supports the involvement of T cell activation in the mode ofaction of DON. An essential step for T cell activation is the activation of
NFAT and translocation of NFAT from the cytoplasm to the nucleus
(Shaffer et al., 2001; Gwack et al., 2007). Therefore, we assessed
whether DON exerts NFAT translocation in primary mouse thymo-
cytes. As shown in Fig. 7, DON induced a rapid translocation of NFAT to
the nucleus within 1 h.
Real time RT-PCR
In order to conﬁrm the expression proﬁles provided by the
microarray analysis, four genes were selected for expression analysis
by quantitative RT-PCR. Genes were selected on basis of a key role in
either T cell activation, negative selection, or ER stress response:
CD86, CD80, Ccl4, and ATF3. The expression patterns of these genes as
assessed by quantitative RT-PCR were very similar to those provided
by the microarray analysis (Fig. 8).
Discussion
This study shows the in vivo effects of DON on gene expression in
mouse thymus cells. Biological interpretation of the gene expression
proﬁles conﬁrmed some already known pathways of DON toxicity but
also put forward yet unknown modes of action. Our results clearly
Fig. 7. Translocation of NFAT after treatment of primary thymocytes with DON. Panels A, B and E: control cells; panels C, D, and F: DON-treated cells. The green ﬂuorescence in panels
A, C, E, and F represents FITC-stained NFAT. Panels B and D show DAPI-stained nuclei. Scale bar represent 15 μm (A–D) and 5 μm (E and F).
Ccl2
0
2
4
6
8
10
12
14
16
18
5 10 25 5 10 25 5 10 25
R
at
io
 c
om
pa
re
d 
to
 c
on
tro
l 3h 6h 24h
CD80
-2
-1
0
1
2
3
4
5
5 10 25 5 10 25 5 10 25
R
at
io
 c
om
pa
re
d 
to
 c
on
tro
l
ATF3
-5
0
5
10
15
20
25
30
35
40
45
5 10 25 5 10 25 5 10 25R
at
io
 c
om
pa
re
d 
to
 c
on
tro
l
CD86
0
1
2
3
4
5
5 10 25 5 10 25 5 10 25R
at
io
 c
om
pa
re
d 
to
 c
on
tro
l
3h 6h 24h
3h 6h 24h 3h 6h 24h
Fig. 8. Real-time PCR. RT-PCR conﬁrmation of microarray data. Quantitative real-time PCR was performed for ATF3, CD80, CD86, and Ccl4. The expression levels of the genes are
relative to Hprt1 and actB.
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310 S.W.M. van Kol et al. / Toxicology and Applied Pharmacology 250 (2011) 299–311indicate that DON induces a T cell activation response, which is
rapidly followed by apoptosis and depletion of thymocytes similarly
to the process of negative selection of precursor thymocytes with self-
recognition. This is in agreement with the thymus being the most
sensitive target organ for DON exposure.
A high number of genes were signiﬁcantly affected after 3 h of
exposure at all doses used. For the 5 and 10 mg/kg bw dose groups,
the number of affected genes was considerably reduced after 6 h,
while only a small number of genes was still affected after 24 h. This
indicates that the effects of 5 and 10 mg/kg DON were reversible. The
limited period of DON toxicity is likely related to the previously
described rapid metabolization and clearance of DON (Pestka, 2007;
Amuzie et al., 2008). In mice treated with 5 mg/kg bw DON,
concentrations have been reported to reach a maximum in plasma
and tissues within 15–30 min and to be reduced by 75–90% after
120 min already (Amuzie et al., 2008). The number of affected genes
induced by 25 mg/kg DON remained constant over time, indicating
that this dose induces an irreversible effect, at least during a period of
24 h.
DON stimulated within 3 h the expression of many genes that are
also activated during the T cell activation response. This conclusion is
partly based on the similarity of our data with those on T
lymphocytes that were activated with either PMA and IL2 or a
combination of cytokines (Feske et al., 2001; Shaffer et al., 2001).
These gene sets include calcium inﬂux-dependent and NFkB target
genes (Fig. 3A). Normally, T cell activation is induced by binding of
the T cell receptor to an antigen. This induces depletion of the
endoplasmatic reticulum calcium stores, which activates NFkB and
evokes a larger calcium inﬂux across the plasma membrane through
calcium transporters. This rise in intracellular calcium activates
calcineurin to dephosphorylate NFAT, which subsequently is translo-
cated to the nucleus where it activates many target genes leading to T
cell activation and proliferation (Gwack et al., 2007). In the present
study, we were able to demonstrate using immunohistochemical
techniques that DON induces translocation of NFAT from the
cytoplasm to the nucleus.
Since DON is not expected to activate the T cell receptor, it likely
induces one of the downstream events after T cell receptor activation.
DON is known to inhibit protein synthesis by binding to the 60 S
ribosomal unit where it interferes with the activity of peptidyltransfer-
ase, preventing polypeptide chain initiation, and elongation (Ueno and
Hsieh, 1985; Pestka, 2008). DON like other ribosome-binding transla-
tional inhibitors also rapidly activates mitogen-activated protein
kinases (MAPKs) via a process termed the “ribotoxic stress response”.
TheseMAPKs include P38MAPK and JNK (Pestka, 2008), which are also
known to be induced during T cell activation and negative selection of
thymocytes. (Rincón et al., 2000; Starr et al., 2003). Therefore, induction
of MAPKs by DON might be one route leading to T cell activation.
Alternatively, the action of DON on the ribosomes at the endoplasmatic
reticulum might cause the endoplasmatic reticulum to release calcium
leading to a T cell activation response.
T cell activation in the thymus is known to induce negative
selection, and our data indicate that this process also occurs after DON
exposure. Genes upregulated within 2 h after induction of negative
selection of mouse double-positive thymocytes in vivo were also
rapidly induced in our experiment by DON. The upregulation of CD40
target genes further supports this ﬁnding (Fig. 3A). CD40 and its ligand
(CD40L) are master regulators of negative selection of thymocytes.
CD40 regulates the expression of different co-stimuli required for
negative selection like CD80, CD86, CD54, CD58, FasL, TNF, and IL-12.
(Li and Page, 2001; Dong et al., 2002). Of those co-stimuli, CD54, CD80,
and CD86 were signiﬁcantly upregulated after 6-h exposure with
10 mg/kg bw. The upregulation of CD80 and CD86 was conﬁrmed
using real-time RT-PCR.
DON appears to induce a quick stimulus to cell activity before it
exerts its toxic activity. Many gene sets related to proliferation(particularly G1–S phase), mitochondria, and ribosomes were
upregulated at 3 h and highly downregulated at 6 and 24 h. This
might be related to induction of T cell activation as well, which is
known to quickly stimulate cells divide (Onur et al., 2009).
GSEA analysis demonstrated downregulation of genes that are
highly expressed in early-precursor T lymphocytes of DN3 to double-
positive stage and upregulation of genes that are highly expressed in
very early or late-precursor T lymphocytes. The most likely explana-
tion for this ﬁnding is that early-precursor T lymphocytes of DN3 to
double-positive stage are more vulnerable for DON treatment than
the late precursor cells. This agrees with previously published ﬁndings
in mice that 12.5 mg/kg DON to induce a decrease of the number of
double-positive cells within 12 h, whereas the number of late
precursor cells (either CD4+, CD8−, or CD4−, CD8+) remained
constant (Islam et al., 2003). The high sensitivity of double-positive
cells agrees with the presently proposed role of T cell activation in
mediating the toxic activity of DON. In the normal thymus, depletion
of precursor T lymphocytes that respond to auto-antigens occurs at
the double-positive stage as well (Starr et al., 2003). Therefore,
double-positive T cells will be much more sensitive for DON-induced
T cell activation than the very early or late precursor T cells.
Genes encoding proteins for cellular components as mitochondria,
ribosomes, and cytoplasm/nuclei were downregulated by DON. It is
tempting to relate the downregulation of ribosome- and protein
translation-related genes to the ribotoxic stress response. Since
mitochondria- and cytoplasm/nuclei-related genes are downregu-
lated as well, these ﬁndings aremore likely correlated to the depletion
of early lymphocytes that have a higher metabolization rate than the
thymus epithelial and stromal cells. Likewise, the upregulation of
genes related to cell adhesion and cytoskeleton is most likely due to
the relative increase of the proportion of stromal cells.
In relation to the toxic effect of DON, it is surprising that the
expression data provide little indications for induction of apoptosis.
This agrees, however, with previously published data showing that
after 12-h treatment with 12.5 mg/kg DON less than 0.5% of the CD4+
CD8+ cells have apoptotic (subdiploid) nuclei (Islam et al., 2003). At
this same time point, however, 25% of the CD4+ CD8+ cells are
depleted from the thymus. Therefore, depletion of DON-affected cells
likely precedes induction of apoptosis, meaning that there were
apoptotic cells present in the thymus, but before the end of the
treatment period, those cells were already depleted from the thymus.
This rapid depletion likely occurs via phagocytosis, which agrees with
our ﬁndings of a fast invasion of leucocytes and macrophages into the
DON-treated thymus. Deletion via phagocytosis is also found during
negative selection in the thymus (Sun and Shi; Elliott et al., 2009).
In summary, the present ﬁndings indicate that DON induces
cellular events that also occur after activation of the T cell receptor,
such as release of calcium from the endoplasmatic reticulum. This T
cell activation is rapidly followed by negative selection of thymocytes,
particularly those at the double-positive stage. At lower exposure
levels (5 and 10 mg/kg), this effect is reversible, while it is irreversible
at least 24 h after exposure to 25 mg/kg. This provides a plausible
explanation for the high sensitivity for DON of immune cells, above all
thymocytes, compared to other cell types.
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